EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), Saint-Denis, France, France
Disclosure information not submitted.
4F-01 - Sociodemographic and birth characteristics associated with initiation of recombinant growth hormone treatment in children: a nationwide study from 2010 to 2023
Monday, August 25, 20254:15 PM - 4:30 PM ET
